WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Stock Ownership - Who owns Aclaris Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aclaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neal WalkerINTERIM CEO2024-12-04118,840$1.52
$180.64kBuy
Neal WalkerINTERIM CEO2024-12-0468,343$3.76
$256.97kSell
Neal WalkerINTERIM CEO2024-12-012,721$4.07
$11.07kSell
Anand MehraDirector2024-11-19666,666$2.25
$1.50MBuy
Neal WalkerINTERIM PRESIDENT AND CEO2024-11-012,721$2.09
$5.69kSell
Neal WalkerINTERIM PRESIDENT AND CEO2024-10-012,722$1.18
$3.21kSell
Kevin BalthaserChief Financial Officer2024-09-01286$1.18
$337.48Sell
Neal WalkerINTERIM PRESIDENT AND CEO2024-09-012,722$1.18
$3.21kSell
Neal WalkerINTERIM PRESIDENT AND CEO2024-08-0943,548$0.72
$31.35kBuy
Braden Michael Leonard10% Owner2024-08-05206,025$1.24
$256.30kBuy

1 of 5

ACRS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRS insiders and whales buy or sell their stock.

ACRS Shareholders

What type of owners hold Aclaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Braden Michael Leonard39.61%28,293,975$92.52MInsider
Bml Capital Management LLC19.95%14,250,000$46.60MInstitution
Fmr LLC12.09%8,637,727$28.25MInsider
Vanguard Group Inc6.56%4,685,498$15.32MInstitution
Ra Capital Management LP6.07%4,339,299$14.19MInsider
Albert Cha5.87%4,191,397$13.71MInsider
Anand Mehra5.83%4,161,083$13.61MInsider
James E. Flynn5.77%4,123,266$13.48MInsider
D E Shaw Co Inc4.72%3,371,849$11.03MInstitution
Millennium Management LLC4.21%3,005,598$9.83MInstitution

1 of 3

ACRS vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRS44.25%55.75%Net BuyingNet Buying
BDSX42.77%52.65%Net BuyingNet Buying
PSNL41.50%31.29%Net BuyingNet Selling
SERA53.28%13.20%Net SellingNet Selling
NOTV13.50%49.24%Net BuyingNet Buying
View Top Diagnostic & Research Stocks

Aclaris Therapeutics Stock Ownership FAQ

Who owns Aclaris Therapeutics?

Aclaris Therapeutics (NASDAQ: ACRS) is owned by 71.25% institutional shareholders, 89.77% Aclaris Therapeutics insiders, and 0.00% retail investors. Braden Michael Leonard is the largest individual Aclaris Therapeutics shareholder, owning 28.29M shares representing 39.61% of the company. Braden Michael Leonard's Aclaris Therapeutics shares are currently valued at $91.11M.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.